Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers

  1. Barlabé, P.
  2. Sostoa, J.
  3. Fajardo, C.A.
  4. Alemany, R.
  5. Moreno, R.
Revue:
Cancer Gene Therapy

ISSN: 1476-5500,  0929-1903

Année de publication: 2020

Volumen: 27

Número: 5

Pages: 383-388

Type: Article

DOI: 10.1038/S41417-019-0110-1 GOOGLE SCHOLAR

Objectifs de Développement Durable

La source de données: Scopus